faculty-detail-img
Contact

Dr. Santhosh Kumar Devadas

Professor and HOD

  • School

    Medical College

  • Department

    Department of Medical Oncology

Dr. Santhosh Kumar Devadas has over 11 years of experience in the field of Medical Oncology and Bone marrow transplantation. His clinical expertise includes blood cancers and stem cell transplantation. His other areas of interest include breast cancer and gynaecological cancer. He has a keen interest in hereditary breast and ovarian cancer syndromes. He heads the Center of Hematology and Bone marrow transplant (CHBMT) at Ramaiah Hospitals and has been instrumental in driving the center towards excellence in outcomes and quality. His research interests include multiple myeloma, qualitative research, implementation research and hereditary cancers.After joining the department, he established standards of care and processes of the BMT program at Ramaiah Hospitals. He also started a PICC (peripherally inserted central catheter) training and care unit at Ramaiah Hospital.He has been instrumental in improving the documentation and filing systems for the department. Dr. Santhosh has contributed to the development of genetic counseling and testing services at Ramaiah Hospitals and spearheaded the first investigator initiated cooperative group trials in Oncology through Hematology cancer consortium. He was also part of creating a patient support group for the hematology patients in the hospital.

Qualifications

  • DM Medical Oncology

    Tata Memorial Hospital, Mumbai, 2014

  • MD General Medicine

    St. John’s Medical College, Bangalore, 2009

  • MBBS

    K.S Hegde Medical Academy, Mangalore, 2005

Experience

Total Years of Experience

11 Years 6 Months

Academic Experience

11 Years 6 Months

Industry Experience

11 Years 6 Months

  • Winner : Dr Reddy’s Award in the exam conducted for Postgraduates in Internal Medicine in 2009
  • Passed the European Society of Medical Oncology (ESMO) Exam conducted on 28th September 2013
  • 2nd Prize : In the quiz conducted at Mumbai Hematology Group meet in Mumbai, March 2014
  • ACORD Fellowship : Awarded the ACORD fellowship to develop a clinical trial protocol at the 2014 Australia and Asia Pacific Clinical Oncology Research Development Workshop conducted in Sydney, Australia, 14-20th September 2014
  • Presented a paper named "Long-term Follow-up data of APML treated with a triple drug regimen - Real-world data from a tertiary care Center" at the JC Patel Award Session of the HEMATOCON 2016
  • Awarded the European Society of Medical Oncology (ESMO) traveling fellowship in September 2017 - Immuno-oncology, Preceptorship - Singapore
  • Awarded the ESMO Traveling fellowship in September 2018 - Advanced Course on Clinical Questions in Prostate Cancer - Singapore, 21-22.9.2018
  • Awarded the best performer in the EGFRm ECHO (Excellence in Communication of Health Care Outcome) Debate held on 26th September 2020 by Pfizer Inc
  • Was elected Member of the National Academy Medical Sciences, New Delhi, India, April 2021
  • Was awarded by Ramaiah Medical College for research Excellence in July 2021 for the highest research output from the medical college between 2019-2021

National Conference Papers
  • Santhosh Kumar D, Dr. Uma, et al. "Interstitial lung disease and Connective tissue disorders." 62nd Annual Conference Association of Physicians of Indian, Panjim 2007 (Oral Presentation).
  • Santhosh Kumar D, Vineeta Shobha, et al. "The Clinical Spectrum of Sarcoidosis." 63rd Annual Conference Association of Physicians of Indian, Cochin, 2008 (Poster).
  • Santhosh Kumar D, Ratnamala Choudry. "A rare case of Chediak Higashi Syndrome." Annual conference of Karnataka Association of Physicians, Manipal, 2008 (Poster).
  • Santhosh Kumar D, Vineeta Shobha, et al. "Thyroid dysfunction in Systemic Lupus Erythematosus." 64th Annual Conference Association of Physicians of India, Greater Noida, 2009 (Poster).
  • Santhosh K Devadas, Hari Menon, et al. "Long term follow-up data of Acute Promyelocytic Leukemia Treated with a Triple Drug Regimen - Real World Data from a Tertiary Care Center" (Oral Presentation). "JC Patel Award Session" during 56th Indian Society of Hematology and Blood Transfusion Conference (HEMATOCON) held in Bangalore, November 2015.
  • Santhosh K Devadas, Navin Khattry, et al. "Long term viability of cryopreserved hematopoietic stem cells at minus 80 °C with DMSO at a concentration of 4.5%." (Poster). 56th Indian Society of Hematology and Blood Transfusion Conference (HEMATOCON) held in Bangalore, November 2015.
  • "Retrospective Evaluation Of Second Malignancies At A Tertiary Care Cancer Center In India." S Devdas, RC Alva - Journal of Cancer Research & Therapeutics, 2017.
International Conference Papers
  • Santhosh Kumar D, Jyoti Bajpayee, et al. "Lymphopenia as a prognostic factor for histological necrosis and treatment compliance in osteosarcoma." SIOP London, 5-8, October 2012 (Poster).
  • Hari Menon, Santhosh Kumar D, et al. "Sequential arsenic trioxide and all-trans-retinoic acid with daunomycin yield early cytogenetic and molecular response in newly diagnosed acute promyelocytic leukemia – data from a tertiary cancer center." American Society Of Hematology, Atlanta, December 8-11, 2012 (Poster).
  • Nishitha Shetty, Santhosh Kumar D, et al. "A prospective single-center study from a developing country to evaluate the prevalence of vitamin-D deficiency in patients with de novo hematologic malignancies." ASCO 2013 (Abstract e18004).
  • Santhosh Kumar D, Shripad D Banavali, et al. "Retrospective analysis of outcomes of patients with relapsed, refractory, and metastatic sarcomas who have received metronomic chemotherapy." SIOP Toronto, 22-25 October 2014 (Poster).
  • Rasmi Palassery1, Santhosh Devadas1, Sumati Hiregouder2, Vinayak Maka1, Kalpana Kumari1, Nalini Kilara1, Damiano Rondelli3. "Development of a Clinical Hematology and Stem Cell Transplant Program to Provide State-of-the-Art and Cost-Effective Treatment to Patients: A Successful Collaboration between a Medical College in India and a Leading Medical University in the United States of America" (id 121428) - Poster Abstract Accepted for Presentation- ASH 2019.
  • "A Study Highlighting the Limited Use of Autologous Hematopoietic Stem Cell Transplant for Fit Elderly Patients with Multiple Myeloma in India" - November 2020 Blood 136(Supplement 1):1-2. Swaroop Revannasiddaiah, Prathap Raja Varma, Apoorva Jagadish, Santhosh Kumar Devadas. Abstract Accepted for Presentation- ASH 2020.
National Journal Papers
  • Successful Treatment of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) with Low Dose Defibrotide,Indian Journal Of Hematology And Blood Transfusion, 2017.
  • Hypomethylating agents use in acute myeloid leukemia: A single-center experience,Indian Journal Of Medical And Paediatric Oncology, 2020.
  • Sequential Treatment of Arsenic Trioxide Followed by All Trans Retinoic Acid with Anthracyclines has Excellent Long-Term Cure in Acute Promyelocytic Leukemia,Indian Journal Of Hematology And Blood Transfusion, 2020.
  • Epidemiology of Adolescent and Young Adult Cancers in a Tertiary Hospital in South India,Indian Journal of Medical & Paediatric Oncology, 2021.
International Journal Papers
  • Is long-term storage of cryopreserved stem cells for hematopoietic stem cell transplantation a worthwhile exercise in developing countries?, Blood Research, 2017.
  • First Global Blood & Marrow Transplant [GlobalBMT] Conference in Kathmandu with experiences from Nepal, India, Singapore, and Sri Lanka. Journal of Global Health, 2018.
  • Antibiotic Lock Therapy for Salvage of Tunneled Central Venous Catheters with Catheter Colonization and Catheter-Related Bloodstream Infection. Transplant Infectious Disease, Accepted Author Manuscript, 2018.
  • Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory, and Metastatic Sarcomas who have received Metronomic Chemotherapy, Gulf Journal Of Oncology, 2019.
  • Clarifications sought for implications of PORTEC-3 in clinics, Lancet Oncology, 2019.
  • Development of clinical hematology and stem cell transplantation program to provide state-of-the-art and cost-effective treatment to patients: a successful collaboration between a medical college in India and a leading medical university in the United States, 2019, BLOOD ADVANCES.
  • Osimertinib in EGFR-Mutated Advanced NSCLC, 2020, New England Journal of Medicine.
  • A potential role for cyclophosphamide in the mitigation of acute respiratory distress syndrome among patients with SARS-CoV-2, 2020, Medical Hypotheses.
  • Further clinical interpretation and implications of KEYNOTE-048 findings, 2020, the lancet.
  • A Study Highlighting the Limited Use of Autologous Hematopoietic Stem Cell Transplant for Fit Elderly Patients with Multiple Myeloma in India, 2020, Blood.
  • The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis, 2022, J Egypt Natl Canc Inst.
  • The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis, 2022, Journal of the Egyptian National Cancer Institute.

  • 2016 - Member Bangalore Hematology Group
  • 2016 - Member Association of Medical Oncologists of India (AMOI)
  • 2015 - Indian Society of Medical & Pediatric Oncology (ISMPO) : Life Member
  • 2014 - Member European Society of Medical Oncology (ESMO)
  • 2017 - Member American Society Of Hematology (ASH)
  • Reviewer - Indian Journal Of Surgical Oncology

Admission 2023

Admission 2023 group

ADDRESS

M S Ramaiah Nagar, MSRIT, Bangalore 560054